Myriad Genetics

myChoice™ HRD

Biomarkers / Diagnostic
Cancer
Companion diagnostic test to identify metastatic breast cancer, ovarian and other tumor types that may be sensitive to iPAPR and/or platinum
3Clinical validation, 2Preclinical Validation, 1R+D
Worldwide